Literature DB >> 7939430

Increasing resistance to penicillin in Streptococcus pneumoniae in southern Sweden.

K Ekdahl1, C Kamme.   

Abstract

The susceptibility to penicillin of 6 prevalent pneumococcal types isolated from nasopharynx in 1992 was compared with that of corresponding types from 1980-82. The 6 types or groups, 6, 9, 14, 15, 19 and 23, constituted 78% of consecutive isolates. 19/204 isolates in 1992 were intermediately resistant (MIC 0.12-1.0 mg/l) in comparison with 1/194 from 1980-82 (p < 0.001). Resistant strains (MIC > or = 2 mg/l) were not found. Of group 15, no fewer than 10/31 isolates were intermediately resistant, which may support the clonal origin and spread of penicillin-resistant pneumococci. At least 5.0% of nasopharyngeal isolates are now intermediately resistant to penicillin. This figure is substantially higher than the 2% earlier reported in Sweden.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7939430     DOI: 10.3109/00365549409011799

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94.

Authors:  S V Nielsen; J Henrichsen
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

2.  Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in northern Norway.

Authors:  T Magnus; B M Andersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

3.  Molecular serotyping and genotyping of penicillin non-susceptible pneumococci: the introduction of new sequence types, Tehran, Iran.

Authors:  M Azarsa; S Ohadian Moghadam; M Rahbar; Z Baseri; M R Pourmand
Journal:  New Microbes New Infect       Date:  2019-09-06

4.  Limited spread of penicillin-nonsusceptible pneumococci, Skåne County, Sweden.

Authors:  Eva Melander; Hans-Bertil Hansson; Sigvard Mölstad; Kristina Persson; Håkan Ringberg
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.